Skip to content

Comparison of oral and intramuscular progesterone in preterm labor

Comparison of pregnancy outcome following oral and intramuscular progesterone use in preterm labor

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190623043981N1
Enrollment
146
Registered
2020-05-04
Start date
2019-02-23
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labour without delivery

Interventions

Intervention 1: In the intervention group one, until 36 weeks of pregnancy, 200 mg capsule containing micronized progesterone called luteogel produced by Tasnim company will be given daily . Intervent

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Single-tone pregnancy alive fetus intact membrane gestational age between 24-36 weeks preterm labor lack of cerclage labor pains in the form of contractions alternating 2 times in 10 minutes or 8 times in 60 minutes cervical dilatation equal to or greater than 1 cm ultrasound of the first 3 months of pregnancy

Exclusion criteria

Exclusion criteria: vaginal bleeding known uterine anomalies fetal anomalies suspicion of intrauterine infection preterm premature rupture of membranes (PPROM) cervical dilation greater than 3 cm fetal death or fetal distress maternal systemic diseases history of taking any medication other than the usual supplements during pregnancy polyhydramnios and oligohydramnios being dangerous for the mother to continue the pregnancy due to medical reasons lack of cooperation of mothers during study

Design outcomes

Primary

MeasureTime frame
Birth weight. Timepoint: after delivery. Method of measurement: Scale.;Gestational age at delivery. Timepoint: after delivery. Method of measurement: patient documents.;Latency period. Timepoint: from beginning of intervention until delivery. Method of measurement: patient documents.;Number of hospitalized neonates in each group. Timepoint: after delivery. Method of measurement: patient documents.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMoeeneh Barkhori Mehni

Kerman University of Medical Sciences

moeeneh1367@gmail.com+98 34 3252 1679

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026